Sanofi (SNY) News Today $48.00 +0.22 (+0.46%) (As of 01:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Jennison Associates LLC Boosts Stock Holdings in Sanofi (NASDAQ:SNY)Jennison Associates LLC raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 938.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,904,445 shares of the company's stock after acquiring an additional 1,720,972 shares during the perNovember 21 at 5:23 AM | marketbeat.comHere’s What Drove Sanofi’s (SNY) EarningsNovember 20 at 11:14 AM | msn.comNorthwest Bancshares Inc. Takes Position in Sanofi (NASDAQ:SNY)Northwest Bancshares Inc. purchased a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 24,814 shares of the company's stock, valued at approximately $1,430,000. OtNovember 20 at 6:58 AM | marketbeat.comFY2024 Earnings Estimate for Sanofi Issued By Zacks ResearchNovember 20 at 1:53 AM | americanbankingnews.comSanofi’s Sarclisa Nears EU Approval for MyelomaNovember 18 at 10:46 PM | markets.businessinsider.comRichard C. Young & CO. LTD. Trims Holdings in Sanofi (NASDAQ:SNY)Richard C. Young & CO. LTD. lowered its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 27.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 34,694 shares of the company's stock after selling 13,159 shares during the period. Richard C. YoNovember 18 at 7:08 AM | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by Thrivent Financial for LutheransThrivent Financial for Lutherans increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 28,890.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,429,219 shares of the company's stock aftNovember 18 at 5:40 AM | marketbeat.comCIBC Asset Management Inc Reduces Stock Position in Sanofi (NASDAQ:SNY)CIBC Asset Management Inc lessened its holdings in Sanofi (NASDAQ:SNY - Free Report) by 31.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 90,417 shares of the company's stock after selling 41,731 shares during theNovember 18 at 4:41 AM | marketbeat.comFY2024 Earnings Forecast for Sanofi Issued By Zacks ResearchSanofi (NASDAQ:SNY - Free Report) - Analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for shares of Sanofi in a research report issued on Wednesday, November 13th. Zacks Research analyst K. Shah now anticipates that the company will post earnings per share of $4November 18 at 1:30 AM | marketbeat.comAtlanta Consulting Group Advisors LLC Purchases New Position in Sanofi (NASDAQ:SNY)Atlanta Consulting Group Advisors LLC acquired a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 19,272 shares of the company's stock,November 17, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Position Increased by Natixis Advisors LLCNatixis Advisors LLC increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 4.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,874,193 shares of the company's stock after buying an addiNovember 16, 2024 | marketbeat.comAnalysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.November 15, 2024 | msn.comFDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin DiseaseNovember 15, 2024 | benzinga.comRegeneron, Sanofi announce FDA accepts Dupixent sBLA for reviewNovember 15, 2024 | markets.businessinsider.comSimplify Asset Management Inc. Invests $11.77 Million in Sanofi (NASDAQ:SNY)Simplify Asset Management Inc. purchased a new stake in Sanofi (NASDAQ:SNY - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 204,143 shares of the company's stock, valued at approximately $11,765,000. Sanofi makes up 0.5% ofNovember 15, 2024 | marketbeat.comSanofi, Regeneron's Dupixent SBLA Accepted For FDA Review To Treat Chronic Spontaneous UrticariaNovember 15, 2024 | markets.businessinsider.comPress Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticariaNovember 15, 2024 | globenewswire.comPress Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaNovember 14, 2024 | globenewswire.comHumanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin PriceNovember 13, 2024 | benzinga.comArjuna Capital Takes Position in Sanofi (NASDAQ:SNY)Arjuna Capital purchased a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) in the third quarter, according to its most recent filing with the SEC. The firm purchased 38,952 shares of the company's stock, valued at approximately $2,245,000. A number of other hedge funds and other institutioNovember 13, 2024 | marketbeat.comSanofi: Diverse Drug Portfolio And Future Pipeline, 4% Dividend Yield Looks AttractiveNovember 13, 2024 | seekingalpha.comSanofi (NASDAQ:SNY) Stock Holdings Boosted by Legacy Capital Wealth Partners LLCLegacy Capital Wealth Partners LLC boosted its position in Sanofi (NASDAQ:SNY - Free Report) by 114.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 24,274 shares of the company's stock after purchasing an adNovember 10, 2024 | marketbeat.comSanofi’s Dupixent Gains EU Approval for Pediatric Eosinophilic EsophagitisNovember 7, 2024 | tipranks.comThe Accumulus Platform Powers Sanofi's Submissions to Multiple Regulators Around the WorldNovember 7, 2024 | globenewswire.comEMA approves Sanofi/Regeneron’s Dupixent for young EoE patientsNovember 7, 2024 | finance.yahoo.comSanofi (NASDAQ:SNY) Lowered to Buy Rating by StockNews.comStockNews.com cut shares of Sanofi from a "strong-buy" rating to a "buy" rating in a research report on Thursday.November 7, 2024 | marketbeat.comRegeneron, Sanofi announce EC approval for DupixentNovember 6, 2024 | markets.businessinsider.comPress Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisNovember 6, 2024 | globenewswire.comQRG Capital Management Inc. Has $8.78 Million Holdings in Sanofi (NASDAQ:SNY)QRG Capital Management Inc. raised its holdings in Sanofi (NASDAQ:SNY - Free Report) by 8.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 152,406 shares of the company's stock after acquiring an aNovember 5, 2024 | marketbeat.comGFS Advisors LLC Acquires 11,655 Shares of Sanofi (NASDAQ:SNY)GFS Advisors LLC grew its stake in Sanofi (NASDAQ:SNY - Free Report) by 1,017.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,800 shares of the company's stock after acquiring an additional 11,655November 3, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Given Consensus Rating of "Moderate Buy" by BrokeragesSanofi (NASDAQ:SNY - Get Free Report) has earned an average recommendation of "Moderate Buy" from the four analysts that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has givenNovember 3, 2024 | marketbeat.comabrdn plc Cuts Stake in Sanofi (NASDAQ:SNY)abrdn plc cut its stake in Sanofi (NASDAQ:SNY - Free Report) by 30.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 250,085 shares of the company's stock after selling 109,348 shares during the period. abrdn plc's holdings in Sanofi were worth $14November 2, 2024 | marketbeat.com122,118 Shares in Sanofi (NASDAQ:SNY) Acquired by International Assets Investment Management LLCInternational Assets Investment Management LLC bought a new stake in Sanofi (NASDAQ:SNY - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 122,118 shares of the company's stock, valued at appNovember 1, 2024 | marketbeat.comSanofi’s Dupixent Shows Promise for Skin DisorderOctober 31, 2024 | markets.businessinsider.comFY2024 EPS Estimates for Sanofi Increased by Leerink PartnrsSanofi (NASDAQ:SNY - Free Report) - Stock analysts at Leerink Partnrs lifted their FY2024 earnings estimates for Sanofi in a note issued to investors on Sunday, October 27th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings of $4.25 per share for the year, up frOctober 30, 2024 | marketbeat.comAllspring Global Investments Holdings LLC Purchases 41,117 Shares of Sanofi (NASDAQ:SNY)Allspring Global Investments Holdings LLC raised its position in Sanofi (NASDAQ:SNY - Free Report) by 434.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,583 shares of the company's stock after buyingOctober 30, 2024 | marketbeat.comChina Universal Asset Management Co. Ltd. Boosts Stake in Sanofi (NASDAQ:SNY)China Universal Asset Management Co. Ltd. grew its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 69.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 56,230 shares of the company's stock afteOctober 29, 2024 | marketbeat.comLeerink Partnrs Estimates Sanofi's Q4 Earnings (NASDAQ:SNY)Sanofi (NASDAQ:SNY - Free Report) - Research analysts at Leerink Partnrs reduced their Q4 2024 EPS estimates for shares of Sanofi in a report issued on Sunday, October 27th. Leerink Partnrs analyst D. Risinger now forecasts that the company will earn $0.83 per share for the quarter, down from theOctober 29, 2024 | marketbeat.comSanofi says Beyfortus to be broadly available in more Canadian territories soonOctober 28, 2024 | markets.businessinsider.comSanofi (NASDAQ:SNY) Posts Quarterly Earnings Results, Beats Expectations By $1.35 EPSSanofi (NASDAQ:SNY - Get Free Report) issued its quarterly earnings data on Friday. The company reported $1.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $1.35. The company had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a return on equity of 20.59% and a net margin of 9.96%. The firm's revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.55 earnings per share.October 28, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Q3 2024 Earnings Call TranscriptOctober 26, 2024 | msn.comSanofi SA (SNY) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic AdvancesOctober 26, 2024 | ca.finance.yahoo.comQ3 2024 Sanofi SA Earnings Call TranscriptOctober 26, 2024 | gurufocus.comWhy Sanofi Stock Flew Higher on FridayOctober 25, 2024 | fool.comSanofi Reports Strong Q3 Growth and Raises EPS GuidanceOctober 25, 2024 | markets.businessinsider.comSanofi (SNY) Q3 2024 Earnings Call TranscriptOctober 25, 2024 | finance.yahoo.comEli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's DupixentOctober 25, 2024 | finance.yahoo.comSanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment PlansOctober 25, 2024 | finance.yahoo.comSanofi (NASDAQ:SNY) Shares Gap Up - Should You Buy?Sanofi (NASDAQ:SNY) Shares Gap Up - Still a Buy?October 25, 2024 | marketbeat.comMediolanum International Funds Ltd Takes $15.03 Million Position in Sanofi (NASDAQ:SNY)Mediolanum International Funds Ltd purchased a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 260,877 shares of the company's stock, valued at approximately $15,034,000. SOctober 25, 2024 | marketbeat.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.890.47▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼2011▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BMY News PFE News BIIB News MRK News JNJ News NVO News NVS News AZN News GSK News TAK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNY Stock Alerts